Speaker | Author | Executive Director, @IQVIA_Institute | Sharing Human Data Science | Providing objective insights for the advancement of human health globally
New York, USA
Joined March 2009
- Tweets1.2K
- Following1.2K
- Followers1.9K
- Likes207
Pinned Tweet
Proud to share the latest publication from the IQVIA Institute: our annual report on Global Trends in R&D. Download for details on the current landscape.
Biopharma R&D is regaining momentum. In 2024, funding reached $102B, emerging biopharma companies led 63% of clinical trial starts, and novel modalities drove 35% of oncology trials.
Download the report: bit.ly/3DEDQQY.
Our latest examines state-level research on pharmacist vaccination authority policies and analyzes state-level adult vaccination rates for the RSV, pneumococcal, and shingles vaccines. Read more.
Empowering pharmacists boosts adult vaccination rates. A new IQVIA Institute report reveals that states granting pharmacists greater vaccine administration authority see improved immunization uptake: bit.ly/41tL7fn. #Vaccines #PublicHealth
See our new report to learn about the #IRA's #Medicare Drug Price Negotiation Program and how it will impact U.S. drug pricing policy.
A new report from @IQVIA_Institute about the Proliferation of Innovation Over Time examines how drug innovation advances post-FDA approval, highlighting impacts of policies like the Inflation Reduction Act. Download now: bit.ly/434wgJt.
105
Learn more about barriers within the RLT patient referral journey in our latest report.
Timely access to radioligand therapy (RLT) depends on efficient referral pathways.
Our new report examines challenges in RLT patient referrals across Germany, Italy, France and China, offering solutions to reduce delays.
Read now: bit.ly/3WLQ14I.
91
Our latest report looks closely at the 'biosimilar void.' Download to learn more.
Biologic medicines make up nearly half of U.S. medicine spending, yet biosimilar competition isn’t guaranteed. With 118 biologics set to lose patent protection by 2034, key barriers could limit development. Explore solutions: bit.ly/4aLA83K. #Biosimilars
67
What is the IQVIA Institute's view of 10 indicators of progress for the #lifesciences sector in 2025? Download our research brief to learn more.
How can the life sciences sector measure progress in 2025?
Our latest research brief identifies key indicators shaping trust, innovation, & access. Learn about driving meaningful advancements for patients & stakeholders: bit.ly/4gLiTlj. #LifeSciences
What is happening in #digitalhealth today and how has it changed over the last few years? Download our newest report to find out.
Innovation in #DigitalHealth remains strong, despite recent market challenges. Our latest report explores trends in diagnostics, digital therapeutics, and AI-driven solutions reshaping care for patients and providers. bit.ly/4itvg6V
74
Latest report from the IQVIA Institute on access to treatments across Europe, Japan, and the U.S. Download to read the findings.
More than 500 novel drugs were approved in the U.S., EU, and Japan from 2014-2022, but access varies widely. The latest IQVIA Institute report examines what drives these disparities and how to improve availability: bit.ly/3ZuNmgi.
119
Latest from IQVIA Institute: Research brief looks at data and context on net drug spending for the first set of drugs selected for negotiations by the U.S. Centers for Medicare & Medicaid Services - including impact on patient out-of-pocket costs.
Just released: IQVIA Institute's latest report on CMS Prescription Drug Negotiations and the impact of the Inflation Reduction Act (IRA) on Medicare drug prices. Full insights here: bit.ly/401LflU #Medicare #PharmaSpending
135
Sharing the latest report from the IQVIA Institute, published today.
Introducing IQVIA Institute's report on Long-term Market Sustainability for Infused Biosimilars in the U.S. Explore insights into the challenges and opportunities shaping the future of biosimilars. 🏥💉
🔗 bit.ly/3Ofba2U #Biosimilars #PharmaSpending
See what's in our latest report, just released today: The Global Use of Medicines 2024.
🌍 IQVIA Institute's latest report on the Global Use of Medicines 2024 is now available. View the trends and forecasts shaping the future of healthcare with an outlook to 2028: bit.ly/41Y9oZL #PharmaInsights #GlobalHealth
160
Check out my latest article: Outlook for 2024: 7 Indicators of Progress in the Life Sciences Sector linkedin.com/pulse/outlook-2… via @LinkedIn
Just published today: IQVIA Institute report on the value of Radioligand Therapy as a treatment for certain cancers.
The latest IQVIA Institute report on Radioligand Therapy (RLT) reveals its clinical benefits in treating various cancers. Despite rapid scientific progress, healthcare system readiness lags behind. Full report: bit.ly/3uNjrnJ #CancerResearch #HealthcareInnovation
Just out today from the IQVIA Institute: Research brief looking at global adult vaccination through lens of five cities.
Read IQVIA Institute's research brief on how urban policies play a pivotal role in ensuring equitable access to adult vaccines. 🏙️💉 Dive into the data from 5 diverse cities - Brussels, Manchester, Bangkok, Chicago, and New York: bit.ly/483Ba8L #GlobalHealth #Vaccines
Discover the findings in this new report from the IQVIA Institute published today. #drugs #drugshortages
🚨A new report from the IQVIA Institute assesses the drug shortages reported by @US_FDA in conjunction with sales and volume data of these medicines in the U.S. market. Download the report to learn the causes and impacts of these shortages: bit.ly/3umDYPK #drugshortages
Learn more about biosimilar development in Europe in this new report from the IQVIA Institute.
🔬Just in: The latest IQVIA Institute report dives deep into the world of biosimilars in Europe. The findings explore the ins and outs of biosimilar development, revealing areas with potential competition and those that need a boost: bit.ly/477ad3y. #Biosimilars
New report out today from the IQVIA Institute with interesting findings on collaborations between #patient orgs and #lifesciences.
IQVIA Institute’s latest report on Supporting Patients through Research Collaboration is live. Learn how life sciences companies can forge better and more productive collaborations with patient organizations: bit.ly/46h9rkF.
#PatientAdvocacy #PatientOutcomes
Today the IQVIA Institute published our annual report on Global Oncology Trends 2023. Download below.
IQVIA Institute's Global Oncology Trends 2023 report examines the current state of research and development in oncology. Read the full report for more trends in the use of novel mechanisms in specific cancer types: bit.ly/3olg6K1
#Oncology #Cancer Research
I hope you will take time to download and share our latest report on The Use of Medicines in the U.S. 2023.
Explore our new report on The Use of Medicines in the U.S. 2023. Learn more about usage and spending trends within the U.S. healthcare system and read about our outlook toward 2027. bit.ly/3neDcBv #Pharma
This report is just out today from the IQVIA Institute, in collaboration with Translucent Datalab and IE University.
New Report: Assessing the Impact of Illegal Online Pharmacies in the U.S.: Sales, Volume and Adverse Events. Learn about the nature and use of illegal online pharmacies in recent years: bit.ly/40D1QsT #SafeMedicines #TranslucentDatalab
